Positron emission tomography (PET) uses radioactive tracers and enables the functional
imaging of several metabolic processes, blood flow measurements, regional chemical …

Immuno-positron emission tomography (immunoPET) is a paradigm-shifting molecular
imaging modality combining the superior targeting specificity of monoclonal antibody (mAb) …

Context The incidental detection of localized renal masses has been rising steadily, but a
significant proportion of these tumors are benign or indolent and, in most cases, do not …

Highlights•Theranostic nanoemulsions hold possibilities to detect and treat cancer
effectively.•Targeting theranostic approaches received great attention for site-specific …

While the development of positron emission tomography (PET) radiopharmaceuticals
closely follows that of traditional drug development, there are several key considerations in …

Combination therapy is becoming imperative for the treatment of many cancers, as it
provides a higher chance of avoiding drug resistance and tumor recurrence. Among the …

Novel molecular imaging opportunities to preoperatively diagnose renal cell carcinoma is
under development and will add more value in limiting the postoperative renal function loss …

Targeted radionuclide therapy has become increasingly prominent as a nuclear medicine
subspecialty. For many decades, treatment with radionuclides has been mainly restricted to …

Target-specific biomolecules, monoclonal antibodies (mAb), proteins, and protein fragments
are known to have high specificity and affinity for receptors associated with tumors and other …

Simple Summary Carbonic anhydrase IX (CAIX) has been explored for a long time as a
therapeutic target in the fight against clear cell renal cell carcinoma and several hypoxic …